Leerink Partnrs Brokers Decrease Earnings Estimates for EHC

Encompass Health Co. (NYSE:EHC) – Leerink Partnrs reduced their Q2 2025 EPS estimates for Encompass Health in a note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $1.18 per share for the quarter, down from their previous estimate of $1.23. The consensus estimate for Encompass Health’s current full-year earnings is $4.76 per share. Leerink Partnrs also issued estimates for Encompass Health’s Q2 2026 earnings at $1.20 EPS, FY2027 earnings at $5.23 EPS and FY2028 earnings at $5.43 EPS.

A number of other research analysts have also issued reports on EHC. KeyCorp upped their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday. StockNews.com lowered Encompass Health from a “buy” rating to a “hold” rating in a research note on Friday, February 7th. Royal Bank of Canada reiterated an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a research note on Tuesday. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, Truist Financial reiterated a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $107.67.

Encompass Health Price Performance

Shares of EHC stock opened at $98.04 on Thursday. The stock’s 50-day simple moving average is $96.06 and its 200-day simple moving average is $95.43. The firm has a market capitalization of $9.88 billion, a price-to-earnings ratio of 21.98, a PEG ratio of 1.18 and a beta of 0.90. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. Encompass Health has a fifty-two week low of $72.53 and a fifty-two week high of $104.55.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. TD Private Client Wealth LLC grew its stake in shares of Encompass Health by 2,870.0% during the 3rd quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock worth $709,000 after purchasing an additional 7,089 shares during the period. Los Angeles Capital Management LLC boosted its holdings in Encompass Health by 532.4% during the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock worth $4,860,000 after buying an additional 42,338 shares in the last quarter. Pathstone Holdings LLC boosted its holdings in Encompass Health by 54.5% during the third quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after buying an additional 7,412 shares in the last quarter. Meeder Asset Management Inc. grew its position in Encompass Health by 43.8% during the third quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock valued at $6,417,000 after buying an additional 20,242 shares during the period. Finally, Geode Capital Management LLC increased its holdings in Encompass Health by 1.2% in the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock valued at $161,781,000 after buying an additional 20,547 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.